@article {1925, title = {Differences in interleukin-6 and interleukin-17 expression in covid-19 post-mortem lung tissue biopsy compared with noncovid- 19}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {January 2023}, pages = {887-892}, type = {Original Article }, chapter = {887}, abstract = {

Background: COVID-19 has spread rapidly around the world. It is necessary to study lung tissue of postmortem COVID19 patients to determine the molecular alteration particularly the role of IL-6 and IL-17 in causing fatality. Objective: This study aims to determine the differences in the expressions of IL-6 and IL-17 in lung tissue of post-mortem COVID-19 patients compared to non-COVID-19 patients. This study also aimed to analyze the correlation between the expressions of IL-6 and IL-17 in lung tissue of post-mortem COVID-19 patients. Methods: This research is an observational analytic study with crosssectional approach. The samples were 15 paraffin blocks of post-mortem lung tissue biopsy of COVID-19 patients, and 15 paraffin blocks of inflammatory lung tissue biopsy or surgery of non-COVID-19 patients. IL-6 and IL-17 expressions were evaluated by immunohistochemical procedure. Result: There was a significant difference in the expression of IL-6 in the COVID-19 group and the non-COVID-19 group with a p-value = 0.001 (p \< 0.05). There was a significant difference in the expression of IL-17 in the COVID-19 group and the non-COVID-19 group with p-value = 0.001 (p \< 0.05). There was a significant correlation between the expressions of IL-6 and IL-17 in the COVID-19 group, with the Spearman coefficient value (rs) of 0.548 with p = 0.034 (p \< 0.05). Conclusion: There are differences in the expression of IL-6 and IL-17 between COVID-19 and non-COVID-19 lung tissue. There is a significant correlation between the expressions of IL-6 and IL-17 in post-mortem lung tissue of COVID-19 patients.

}, keywords = {Biopsy, COVID-19, IL-17, IL-6, Post mortem lung tissue.}, doi = {10.5530/pj.2022.14.184}, author = {Etty Hary Kusumastuti and Priangga Adi Wiratama and Grace Ariani and Stephanie Natasha Djuanda and Alphania Rahniayu and Nila Kurniasari and Dyah Fauziah and Anny Setijo Rahaju and Isnin Anang Marhana and Alfian Nur Rosyid and Dwi Wahyu and Gilang Muhammad Setyo Nugroho and Adhitri Anggoro and I Komang Rusgi Yandi and Bambang Pujo Semedi and Jilientasia Godrace Lilihata and Ummi Maimunah and Supriadi and Achmad Lefi and Lalu Galih Pratama Rinjani and Edi Suyanto and Ricardo Ardian Nugraha} } @article {1856, title = {Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Histological Feature: A Case Report}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {August 2022}, pages = {459-461}, type = {Case Report}, chapter = {459}, abstract = {

Introduction: Nephrotic syndrome is a clinical syndrome of heavy proteinuria and hypoalbuminemia or hypoproteinemia. Renal biopsy is fundamental to assess not only the type but also the degree of disease activity. The overall prognosis and response to treatment often depend on the severity of histological lesions and their reversibility.1,2 Case Presentation: An eighteen years old man with nephrotic syndrome and planned for a kidney biopsy. This case showed a patient with swollen face (especially on the cheek). On Biopsy results showing the glomerulus proliferation of cells and mesangeal matrix, adhesions in (50\%) glomerulus, focal sclerosis in some glomeruli, erythrocyte cells visible in the urinary space and thickening of the basement membrane in some glomeruli, partially atrophic tubules, visible erythrocytes in the tubular lumen. Conclusion: An eighteen years old man with nephrotic syndrome with cushing syndrome and hypokalemia who had a renal biopsy. The histological feature from the renal biopsy was focal segmental glomerulosclerosis. The underlying cause of FSGS is still unclear. Assessing the diagnosis and etiology become important to direct the subsequent clinical approach and therapy

}, keywords = {Focal segmental glomerulosclerosis, Nephrotic syndrome, Renal biopsy}, doi = {10.5530/pj.2022.14.122}, author = {Dian Samudra and Widodo and Nunuk Mardiana and Artaria Tjempakasari and Pranawa and Aditiawardana and Anny Setijo Rahaju} } @article {1911, title = {The Potential of Antivirus Compounds in Gletang (Tridax procumbens Linn.) in Inhibiting 3CLpro Receptor of SARS-CoV-2 Virus by In Silico}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {December 2022}, pages = {796-805}, type = {Research Article }, chapter = {796}, abstract = {

SARS-CoV-2 virus has caused pandemic disease since the end of 2019. Virus transmission occurs through droplet and infects the host{\textquoteright}s respiratory tract rapidly. Viral propagation occurs through translation process of genome +ssRNA, then it being replicated forming some new body parts of virus and assemblied into virions that ready to infect. During the replication process, the translated viral genome in the form of polyprotein will be cut into smaller components by proteases, which one is 3CLpro. The presence of the 3CLpro receptor is used in drug development through in-silico molecular docking process to minimize failures before laboratory test. The antivirus compounds that used to inhibit the 3CLpro receptor are from gletang plant (Tridax procumbens Linn.). This study aim is to determine the value of binding affinity, the interaction between compounds and receptor, and the effect of drug components. The research was conducted by in-silico through the molecular docking process of 3CLpro receptor and antivirus compounds of gletang (Tridax procumbens Linn.), including betulinic acid, kaempferol and lignan. The results showed that the binding affinity of betulinic acid was -6.6 kcal/mol, kaempferol was -5.6 kcal/ mol and lignan was -5.4 kcal/mol. The interaction form of compounds and receptor was hydrogen bond, electrostatic, hydrophobic, and van der Waals. Compared to baicalein compound as a positive control with the value of binding affinity was -6.7 kcal/mol and its interaction with 3CLpro receptor, showed betulinic acid, kaempferol and lignan have smaller ability but they have the potential to inhibit the 3CLpro receptor.

}, keywords = {3CLpro receptor, Antivirus, Gletang, In-silico, SARS-CoV-2.}, doi = {10.5530/pj.2022.14.170}, author = {Yuna Islamiati and Yani Suryani and Ayuni Adawiyah and Opik Taufiqurrohman and Viol Dhea Kharisma and Devi Purnamasari and Nunuk Hariani Soekamto and Anny Setijo Rahaju and Kuswati and Riso Sari Mandeli and Kawther Ameen Muhammed Saeed Aledresi and Nur Farhana Mohd Yusof and Maksim Rebezov and Shimanovskaya Yanina and Belyakova Natalia and Dmitriy Kulikov and Gulnara Mullagulova and Rahadian Zainul and Muhammad Thoriq Albari} } @article {1788, title = {Virgin coconut oil and tuberculosis: A mini-review}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {April 2022}, pages = {464-469}, type = {Mini-Review}, chapter = {464}, abstract = {

Virgin coconut oil is widely promoted and used as healthy and beneficial oil. One of them is caused by antimicrobials. Caprylic, caproic acid, capric acid, lauric acid and tau glyceryl monolaurate are other VCO compositions. Furthermore, due to the non-heating manufacturing process, the content in VCO can reduce cholesterol levels of triglycerides, LDL, phospholipids, VLDL and increase HDL in blood serum. VCO consumption lowers the number of Mycobacterium tuberculosis colonies while increasing the conversion of BTA sputum. Until now, the prevalence of tuberculosis (TB) disease was extremely high. VCO can be used as a supplement to help TB patients recover faster.

}, keywords = {Mycobacterium tuberculosis, Tuberculosis, Virgin coconut oil}, doi = {10.5530/pj.2022.14.59}, author = {Fathul Djannah and Muhammad Nasrum Massi and Mochammad Hatta and Agussalim Bukhari and Irda Handayani and Muhammad Faruk and Anny Setijo Rahaju} }